REVERSED PHASE-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD DEVELOPMENT AND VALIDATION OF ATORVASTATIN IN BULK DRUG AND FORMULATION
Objective: To develop and validate a simple, selective, rapid, precise, and accurate high performance liquid chromatographic (HPLC) method for
determination of atorvastatin in bulk and its pharmaceutical formulation product.
Method: Reversed phase-HPLC (RP-HPLC) method was performed by a mobile phase consisting mixture of methanol and ammonium acetate buffer
(pH 4.5) in the proportion 60:40 v/v. A ZORBAX Eclipse plus C
(4.6 mm Ã— 100 mm, 3.5 Î¼) column was used as a stationary phase. HPLC analysis of
atorvastatin was carried out at a wavelength of 241 nm with a flow rate of 1 ml/minute.
Results: The linear regression analysis data for the calibration curve showed a good linear relationship with a correlation coefficient 0.9984. The
linear regression equation was y=3726540.2x+27390388.1. This was found to give a sharp peak of atorvastatin at a retention time of 2.77 minutes.
Validation parameters were evaluated for the method according to the ICH (Q2R1) guidelines. The limit of detection and limit of quantification for the
method were 0.6721 Î¼g/mL and 1.9989 Î¼g/mL, respectively. The % relative standard deviation values for intra-day precision and inter-day precision
were found to be 0.31% and 0.30%, respectively. An accuracy of the method was determined through recovery studies which were found to be within
Conclusion: The method was validated for system suitability, accuracy, precision, robustness, and ruggedness. The precision, accuracy, sensitivityshort retention time and composition of the mobile phase indicated that this method is better than the earlier methods developed for the quantification
Keywords: Atorvastatin, Reversed phase-high performance liquid chromatographic method development, Validation.
and validation of RP-HPLC method for the estimation of atorvastatin in
bulk and Tablet dosage form. Int J Pharm Sci 2012;2(4):91-3.
2. Anjum F, Radhika T, Kumari KR, Ajitha M. Int Res J Pharm
3. Available from: https://www.google.co.in/webhp?sourceid=chromeinstant&ion=1&espv=2&ie=UTF-8#q=atorvastatin+drug+bank.
on 2015 Jun 20].
4. Nash RA. Pharmaceutical Process Validation, An International 3
Revised and Expanded. Vol. 129. New York: Eastern Hemisphere
Distribution, Marcel Dekker, Inc; p. 507-22.
5. Chatwal GR. Instrumental Methods of Chemical Analysis. Mumbai:
Himalaya Publishing House; 1979. p. 2.566-2.699.
6. ICH, Q2B, Harmonised Tripartite Guideline, Validation of Analytical
Procedure: Methodology, IFPMA. In: Proceedings of the International
Conference on Harmonisation. Geneva: March, 1996.
7. Snyder LR. Practical HPLC Method Development. 2
ed. New York:
8. Kumar P, Ghosh A, Chaudhary M. Stability indicating method
development for simultaneous estimation of ezetimibe and atorvastatin in
pharmaceutical formulations by RP-HPLC. Pharm Anal Acta 2012;3:6.
9. Ahmed M, Manohara YN, Ravi MC. RP-HPLC method development
and validation for simultaneous estimation of atorvastatin calcium and
amlodipine besylate. Int J ChemTech Res 2012;4(1):337-345.
10. Surekha ML, Swamy GK, Kumar DV. Development and validation of
RP-HPLC method for the estimation of atorvastatin in bulk and tablet
dosage form. Int J Pharma Sci 2012;2(4):91-3.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.